Chronic Pseudomonas Aeruginosa Infection clinical trials at UCSF

1 research study open to eligible people

Phage for CF Subjects With Pseudomonas Lung Infection
open to eligible people ages 18 years and up
The goal of this Phase 2b clinical trial is to see if nebulized phage (BX004) can treat chronic Pseudomonas aeruginosa (PsA) lung infection in CF subjects. The primary goal is to see if 8 weeks of twice daily BX004 can reduce the amount of PsA in the sputum compared to placebo (on top of background CF therapy).
San Francisco, California and other locations

Last updated: July 17, 2025

Phage for CF Subjects With Pseudomonas Lung Infection